Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease

Urology(2022)10.1016/j.urology.2022.04.003Source: DataRank Database

Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease is a research paper published in Urology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (11 grants)Impact (FWCI 0.82)OA: hybridTopics (35)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Christopher J. Ricketts ORCID,Adam R. Metwalli ORCID,Peter A. Pinto ORCID,Rabindra Gautam,Mark Raffeld ORCID

Live enrichment

PubMed:35469800 PMC:PMC9296614 OpenAlex:https://openalex.org/W4224945274

Intramural NIH HHS

Grant: Z01 BC011038

Intramural NIH HHS

Grant: Z01 BC011028

Intramural NIH HHS

Grant: Z01 BC011044

Intramural NIH HHS

Grant: Z01 BC011089

Intramural NIH HHS

Grant: ZIA BC011038

Intramural NIH HHS

Grant: ZIC BC011044

Intramural NIH HHS

Grant: ZID BC011089

Intramural NIH HHS

Grant: Z01 BC011095

Intramural NIH HHS

Grant: ZIA BC011028

National Institutes of Health

Grant: 1ZIABC011028-09

Clinical Studies of the Molecular Genetic Basis of Kidney Cancer

National Cancer Institute

FWCI

0.82

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

hybridLicense: cc-by-nc-nd

journalhttp://www.goldjournal.net/article/S009042952200303X/pdf

publisherhttp://www.goldjournal.net/article/S009042952200303X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S009042952200303X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S009042952200303X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.urology.2022.04.003

Fields of Study

Renal cell carcinoma treatmentMultiple and Secondary Primary CancersRenal and related cancers03 medical and health sciences0302 clinical medicine

MeSH Terms

Carcinoma, Renal CellHumansKidney NeoplasmsMutationDNA MethylationVon Hippel-Lindau Tumor Suppressor Protein

Keywords

MedicineRenal cell carcinomaClear cell renal cell carcinomaSomatic cellMetastasisKidney cancerGermline mutationPrimary tumorVon Hippel–Lindau diseaseMutationPathologyCancer researchCancerOncologyDiseaseInternal medicineGeneBiologyGeneticsVon Hippel-Lindau Tumor Suppressor ProteinHumansDNA MethylationCarcinoma, Renal CellKidney Neoplasms

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being